DENTSPLY SIRONA Inc. ($XRAY) Stock Forecast: Up 5.2% Today

What is DENTSPLY SIRONA Inc.?

Asset Dentsply Sirona (NASDAQ: XRAY) is a company specializing in dental equipment and technology. Today, the stock had a strong bullish movement.

Why is DENTSPLY SIRONA Inc. going up?

XRAY stock is up 5.2% on Jul 22, 2025 19:51

• The appointment of Daniel Scavilla as the new Chief Executive Officer of Dentsply Sirona appears to have boosted investor confidence, given his significant background in the medical technology and pharmaceutical sectors, potentially leading to positive changes within the company.
• The company's upbeat preliminary results for the second quarter and reaffirmation of its 2025 outlook likely played a role in the bullish movement, indicating robust performance and consistency.
• Investor sentiment might have been further bolstered by the company's advancements in digital implants, research and development capabilities, as well as margin growth despite facing challenges in certain markets, highlighting reasons to consider adding Dentsply Sirona stock to portfolios.

XRAY Price Chart

XRAY Technical Analysis

XRAY News

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer - Globus Medical ( NYSE:GMED ) , Dentsply Sirona ( NASDAQ:XRAY )

CHARLOTTE, N.C., July 21, 2025 ( GLOBE NEWSWIRE ) -- DENTSPLY SIRONA Inc. ( "Dentsply Sirona" or "the Company" ) XRAY today announced that Daniel Scavilla, an established business leader with more than three decades of experience in the medical technology and pharmaceutical industries and a ...

https://www.benzinga.com/pressreleases/25/07/g46516601/dentsply-sirona-appoints-daniel-scavilla-as-chief-executive-officer

Dentsply Sirona Appoints Daniel Scavilla as Chief Executive Officer

Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook Provides Select Preliminary Second Quarter 2025 Results and Reaffirms 2025 Outlook ...

https://www.globenewswire.com/news-release/2025/07/21/3118712/0/en/Dentsply-Sirona-Appoints-Daniel-Scavilla-as-Chief-Executive-Officer.html

Reasons to Add DENTSPLY SIRONA Stock to Your Portfolio Now

XRAY gains traction with digital implants, R&D strength, and Q1 margin growth despite softness in Europe.

https://www.zacks.com/stock/news/2586094/reasons-to-add-dentsply-sirona-stock-to-your-portfolio-now

Trending Today

Ethereum ($ETH) Crypto Forecast: Up 6.0% Today

XRP ($XRP) Crypto Forecast: Up 7.4% Today

Fortinet Inc. ($FTNT) Stock Forecast: Down 23.1% Today

ServiceNow Inc. ($NOW) Stock Forecast: Down 5.1% Today

Warner Bros. Discovery, Inc. ($WBD) Stock Forecast: Down 7.3% Today

Tandem Diabetes Care, Inc. ($TNDM) Stock Forecast: Down 20.7% Today

Opendoor Technologies Inc. ($OPEN) Stock Forecast: Down 11.1% Today

Airbnb Inc. ($ABNB) Stock Forecast: Down 9.2% Today

New York Times Company (The) ($NYT) Stock Forecast: Down 5.2% Today

Insulet Corporation ($PODD) Stock Forecast: Up 5.7% Today

DENTSPLY SIRONA Inc. Price History

09.04.2025 - XRAY Stock was up 5.3%

• Following the release of its Q1 earnings report, XRAY stock experienced a strong bullish movement.
• The company reported better-than-expected earnings per share (EPS) of $0.43, surpassing the $0.30 estimate, and exceeded revenue expectations with sales of $879 million.
• Despite a slight decrease in gross margin, Dentsply Sirona's performance in the face of global macroeconomic challenges impressed investors, resulting in a surge in the stock price.
• The company raised its FY25 sales guidance to $3.60 billion-$3.70 billion and reaffirmed the EPS range of $1.80-$2.00, boosting investor confidence in its future prospects and driving the bullish market movement.

02.09.2024 - XRAY Stock was down 5.5%

• The decline in XRAY's stock price could be linked to various macroeconomic challenges, including weakened global demand, increased costs, and currency fluctuations.
• Despite its diverse product portfolio, these external factors appear to have impacted investor sentiment, leading to the stock's downturn.
• Investors may remain wary about the company's future performance until there is more clarity on DENTSPLY SIRONA's strategy to address the current economic challenges.

25.09.2024 - XRAY Stock was down 5.3%

• Dentsply Sirona's decision to voluntarily suspend sales and marketing of Byte Aligners and Impression Kits could have raised concerns among investors about the company's revenue stream and future growth prospects.
• The upcoming conference call to discuss updates on Byte Aligner products might have failed to reassure investors, leading to a lack of confidence in the company's ability to address the issues effectively.
• The select preliminary third-quarter results provided by Dentsply Sirona could have indicated weaker performance than expected, contributing to the negative sentiment surrounding the stock.

13.08.2024 - XRAY Stock was up 5.2%

• The launch of Primescan 2, the new-generation intraoral scanner, is anticipated to fuel growth and market sentiment for XRAY.
• The innovative technology is expected to draw in more customers and bolster the company's competitiveness in the dental equipment sector.
• Investors are positive about the potential rise in revenue and enhanced customer satisfaction resulting from Primescan 2, contributing to today's bullish market movement.

08.04.2025 - XRAY Stock was up 17.4%

• XRAY stock saw a significant bullish movement following the company's impressive Q1 earnings and revenue beat.
• Despite a slight decrease in gross margin, investors were encouraged by DENTSPLY SIRONA's customer-centric innovation and operational efficiency, which contributed to its strong performance in the face of global macroeconomic challenges.
• The market reacted positively to the company's ability to navigate the challenging economic environment, showing confidence in its long-term growth prospects.

11.11.2024 - XRAY Stock was up 5.2%

• The bullish movement in XRAY stock could be attributed to investors finding reasons to retain Dentsply Sirona stock in their portfolios despite the ongoing challenges.
• The pending securities fraud class action lawsuit may have initially caused some uncertainty and volatility in the stock price, but investors seem to have gained confidence in the company's product portfolio.
• Despite the deadline alerts reminding investors of potential losses, the stock managed to have a strong bullish movement, indicating that some positive news or developments might have overshadowed these concerns.
• Overall, the market movement suggests that investors are focusing more on the company's product traction and potential growth rather than the pending legal issues and macroeconomic challenges.

21.04.2025 - XRAY Stock was down 5.0%

• The news about Dentsply Sirona's involvement in an upcoming conference did not generate enthusiasm among investors, resulting in a downward trend in XRAY stock.
• Investors may be anticipating more substantial developments or announcements from the company beyond conference participation.
• The limited positive market reaction suggests investors are looking for concrete progress or growth opportunities from Dentsply Sirona to boost the stock price.

07.10.2024 - XRAY Stock was down 25.2%

• Despite exceeding earnings and revenue expectations in the third quarter, Dentsply Sirona's stock faced downward pressure following a revised guidance for fiscal 2024.
• The revised forecast for 2024, attributed to macroeconomic factors, competition, and lower demand, elicited concerns among investors and led to a decline in the stock price.
• The market response may reflect apprehension surrounding future growth despite positive performance in specific segments during the quarter.
• Investors appear to be adopting a wary stance towards Dentsply Sirona until there is more clarity on the company's strategies to tackle the challenges affecting its future financial outlook.

07.10.2024 - XRAY Stock was down 19.9%

• The bearish movement in XRAY could be due to investors anticipating weaker-than-expected third-quarter earnings.
• Despite growth in specific segments like Wellspect Healthcare and Orthodontics, foreign exchange headwinds may have impacted overall performance.
• Investors might be taking a cautious approach, leading to a sell-off of XRAY shares before the earnings report.
• The uncertainty surrounding the company's financial performance in the face of external challenges could be driving the bearish sentiment in the market.

14.00.2025 - XRAY Stock was down 0.9%

• The decline in XRAY's stock price is potentially linked to ongoing securities class action lawsuits against the company.
• Investor sentiment appears to be negative due to concerns over legal uncertainties, prompting a sell-off of XRAY shares.
• There is a looming deadline for investors to secure counsel by January 27, 2025, which may be further impacting the stock price.
• Overall, market sentiment towards XRAY is bearish as investors assess the potential implications of the legal proceedings on the company's financial performance and reputation.

27.01.2025 - XRAY Stock was down 5.6%

• The bearish movement in XRAY's stock today could be attributed to the tough fourth-quarter performance.
• Factors such as revenue loss from Byte, weak demand for U.S. equipment, and implant pressures may have contributed to investor concerns and selling pressure on the stock.
• Investors may be reacting to the potential impact of these challenges on XRAY's financial performance and future prospects, leading to the bearish movement in the stock today.

22.06.2025 - XRAY Stock was up 5.2%

• The appointment of Daniel Scavilla as the new Chief Executive Officer of Dentsply Sirona appears to have boosted investor confidence, given his significant background in the medical technology and pharmaceutical sectors, potentially leading to positive changes within the company.
• The company's upbeat preliminary results for the second quarter and reaffirmation of its 2025 outlook likely played a role in the bullish movement, indicating robust performance and consistency.
• Investor sentiment might have been further bolstered by the company's advancements in digital implants, research and development capabilities, as well as margin growth despite facing challenges in certain markets, highlighting reasons to consider adding Dentsply Sirona stock to portfolios.